Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.

@article{Hussler2010SafetyAP,
  title={Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.},
  author={Marc D H{\"a}ussler},
  journal={Acta radiologica},
  year={2010},
  volume={51 8},
  pages={924-33}
}
BACKGROUND Iodinated radiographic contrast media are considered safe diagnostic drugs with a low incidence of adverse drug reactions. PURPOSE To determine prospectively the incidence and nature of immediate and delayed adverse drug reactions occurring after administration of iodixanol for contrast-enhanced computed tomography (CT) in routine practice in nonselected patients, and to assess patient comfort (pain and sensations of heat or coldness). MATERIAL AND METHODS Patient characteristics… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…